Selection of an Escherichia coli O157:H7 bacteriophage for persistence in the circulatory system of mice infected experimentally.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Clinical Microbiology and Infection

• Publication date

  2006-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/J.1469-0691.2005.01340.XPMID 16451412
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plant Cell-Based Intimin Vaccine Given Orally to Mice Primed with Intimin Reduces Time of Escherichia coli O157:H7 Shedding in Feces

  2004cited by this paper
• Phage offer a real alternative

  2004cited by this paper
• Vincent Fischetti-following phages for life

  2004cited by this paper
• Vincent Fischetti--following phages for life. Interview by Marilynn Larkin.

  2004cited by this paper
• Therapeutic use of bacteriophages.

  2004cited by this paper
• The prospect for bacteriophage therapy in Western medicine

  2003cited by this paper
• Use of Genetically Engineered Phage To Deliver Antimicrobial Agents to Bacteria: an Alternative Therapy for Treatment of Bacterial Infections

  2003cited by this paper
• Bacteriophage T4 Genome

  2003cited by this paper
• The future of bacteriophage biology

  2003cited by this paper
• Stalin's Forgotten Cure

  2002cited by this paper
• Bacteriophage Therapy Rescues Mice Bacteremic from a Clinical Isolate of Vancomycin-Resistant Enterococcus faecium

  2002cited by this paper
• The In Vitro Interaction of Streptococcus pyogenes with Human Pharyngeal Cells Induces a Phage-Encoded Extracellular DNase

  2002cited by this paper
• Prevalence of Escherichia coli O157:H7 prophage-like sequences among German Salmonella enterica serotype Typhimurium phage types and their use in detection of phage type DT104 by the polymerase chain reaction.

  2002cited by this paper
• A bacteriolytic agent that detects and kills Bacillus anthracis

  2002cited by this paper
• Rapid Killing of Streptococcus pneumoniae with a Bacteriophage Cell Wall Hydrolase

  2001cited by this paper
• Understanding bacteriophage therapy as a density-dependent kinetic process.

  2001cited by this paper
• Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme

  2001cited by this paper
• Bacteriophage Therapy

  2001cited by this paper
• Phage therapy: The peculiar kinetics of self‐replicating pharmaceuticals

  2000cited by this paper
• Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands

  2000cited by this paper
• The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.

  2000cited by this paper
• A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans

  2000cited by this paper
• Multiplex PCR for Detection and Identification of Lactococcal Bacteriophages

  2000cited by this paper
• Evolutionary relationships among diverse bacteriophages and prophages: all the world's a phage.

  1999cited by this paper
• Biocontrol of Escherichia coli O157 with O157-Specific Bacteriophages

  1999cited by this paper
• Pathogenesis and Diagnosis of Shiga Toxin-Producing Escherichia coli Infections

  1998cited by this paper
• Escherichia coli O157:H7

  1998cited by this paper
• Experimental evolution of parasites.

  1998cited by this paper
• Taxonomy of bacterial viruses: establishment of tailed virus genera and the other Caudovirales

  1998cited by this paper
• Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215

  1997cited by this paper
• Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential.

  1997cited by this paper
• Long-circulating bacteriophage as antibacterial agents.

  1996cited by this paper
• Detection of entero- and verocyto-toxin genes in Escherichia coli from diarrhoeal disease in animals using the polymerase chain reaction.

  1992cited by this paper
• The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome.

  1991cited by this paper
• Isolation and Characterization of a Coliphage Specific for Escherichia coli 0157:H7.

  1990cited by this paper
• Infection by verocytotoxin-producing Escherichia coli

  1989cited by this paper
• The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages.

  1987cited by this paper
• Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs.

  1983cited by this paper
• Cytogenetic Effects in Corn Exposed to Atomic Bomb Ionizing Radiation at Bikini.

  1948cited by this paper

• The application of bacteriophage to veterinary and One-Health medicine—a road map

  2026cites this paper
• Selective bacteriophages reduce the emergence of resistant bacteria in bacteriophage-antibiotic combination therapy

  2024cites this paper
• Quis Custodiet? Are Regulations Slowing Phage Therapy?

  2024cites this paper
• Translating phage therapy into the clinic: Recent accomplishments but continuing challenges

  2023cites this paper
• A novel coli myophage and antibiotics synergistically inhibit the growth of the uropathogenic E. coli strain CFT073 in stoichiometric niches

  2023cites this paper
• Chicken liver is a potential reservoir of bacteriophages and phage‐derived particles containing antibiotic resistance genes

  2022cites this paper
• Isolation and characterization of a novel Escherichia coli phage Kayfunavirus ZH4

  2022cites this paper
• The potential of bacteriophage therapy in the treatment of paediatric respiratory infections.

  2022cites this paper
• Interactions of Bacteriophages with Animal and Human Organisms—Safety Issues in the Light of Phage Therapy

  2021cites this paper
• Pharmacokinetics and Pharmacodynamics of a Novel Virulent Klebsiella Phage Kp_Pokalde_002 in a Mouse Model

  2021cites this paper
• Efficacy of phage therapy in pigs: systematic review and meta-analysis

  2021cites this paper
• Bacteriophages and their potential for treatment of gastrointestinal diseases

  2021cites this paper
• Microbiome and cancer.

  2021cites this paper
• The Role of Antibiotic Resistant A. baumannii in the Pathogenesis of Urinary Tract Infection and the Potential of Its Treatment with the Use of Bacteriophage Therapy

  2021cites this paper
• Phage Therapy: The Pharmacology of Antibacterial Viruses.

  2020cites this paper
• Bacteriophages and Lysins as Possible Alternatives to Treat Antibiotic-Resistant Urinary Tract Infections

  2020cites this paper
• Phages and their potential to modulate the microbiome and immunity

  2020cites this paper
• Phage Therapy as a Novel Strategy in the Treatment of Urinary Tract Infections Caused by E. Coli

  2020cites this paper
• Bacteriophages engineered to display foreign peptides may become short‐circulating phages

  2019cites this paper
• Phage resistance evolution in vitro is not reflective of in vivo outcome in a plant‐bacteria‐phage system *

  2019cites this paper
• Managing urinary tract infections through phage therapy: a novel approach

  2019cites this paper
• Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies

  2019cites this paper
• Bacteriophage interactions with mammalian tissue: Therapeutic applications.

  2019cites this paper
• Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review

  2019cites this paper
• Natural and Environmentally Friendly Strategies for Controlling Campylobacter jejuni Colonization in Poultry, Survival in Poultry Products and Infection in Humans

  2019cites this paper
• Phage Therapy Approaches to Reducing Pathogen Persistence and Transmission in Animal Production Environments: Opportunities and Challenges

  2017cites this paper
• Study the pharmacokinetic of the Staphylococcus aureus specific bacteriophage in healthy animals

  2017cites this paper
• Phage engineering: how advances in molecular biology and synthetic biology are being utilized to enhance the therapeutic potential of bacteriophages

  2017cites this paper
• A minireview on the in vitro and in vivo experiments with anti-Escherichia coli O157:H7 phages as potential biocontrol and phage therapy agents.

  2017cites this paper
• Phage Therapy: A New Horizon in the Antibacterial Treatment of Oral Pathogens.

  2017cites this paper
• Use of Bacteriophages to Control Escherichia coli O157:H7 in Domestic Ruminants, Meat Products, and Fruits and Vegetables

  2017cites this paper
• Investigating the potentials of phage therapy in burkholderia pseudomallei infection / Ong Guang Han

  2016cites this paper
• Review: phage therapy: a modern tool to control bacterial infections.

  2015cites this paper
• Bacteriophage-Targeted Nanomedicine and Molecular Imaging

  2014cites this paper
• Fagoterapia frente a infecciones por Staphylococcus aureus meticilino resistente en ratones

  2014cites this paper
• Phage Therapy Is Effective against Infection by Mycobacterium ulcerans in a Murine Footpad Model

  2013influential citation
• Bacteriophages in Health and Disease

  2012cites this paper
• A Method for Generation Phage Cocktail with Great Therapeutic Potential

  2012cites this paper
• Propionibacterium acnes Bacteriophages Display Limited Genetic Diversity and Broad Killing Activity against Bacterial Skin Isolates

  2012cites this paper
• Bacterial Skin Isolates againstLimited Genetic Diversity and Broad Killing Activity Bacteriophages Display Propionibacterium acnes 2012

  2012cites this paper
• Bacteriophage therapy revisited

  2012cites this paper
• The global need for effective antibiotics-moving towards concerted action.

  2011cites this paper
• Modified phages: novel antimicrobial agents to combat infectious diseases.

  2011cites this paper
• Fighting bacterial infections-future treatment options.

  2011cites this paper
• The global need for effective antibiotics-a summary of plenary presentations.

  2011cites this paper
• ighting bacterial infections — Future treatment options

  2011cites this paper
• Ecological Basis for Rational Phage Therapy

  2010cites this paper
• Phage therapy.

  2009cites this paper
• Host range and lytic capability of four bacteriophages against bovine and clinical human isolates of Shiga toxin‐producing Escherichia coli O157:H7

  2009cites this paper
• Bacteriophage Treatment of Burn Wound Infection Caused by Pseudomonas aeruginosa PAO in BALB/c Mice

  2009cites this paper
• Blood kinetics of four intraperitoneally administered therapeutic candidate bacteriophages in healthy and neutropenic mice

  2009cites this paper
• Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials

  2009cites this paper
• Efficacy of bacteriophage treatment in murine burn wound infection induced by klebsiella pneumoniae.

  2009cites this paper
• Bacteriophage biocontrol in animals and meat products

  2009cites this paper
• Comparison of fecal versus rectoanal mucosal swab sampling for detecting Escherichia coli O157:H7 in experimentally inoculated cattle used in assessing bacteriophage as a mitigation strategy.

  2008cites this paper
• Phage Therapy of Pseudomonas aeruginosa Infection in a Mouse Burn Wound Model

  2007cites this paper
• Experimental Phage Therapy against Staphylococcus aureus in Mice

  2007cites this paper
• The Nramp1AA genotype confers susceptibility to Brucella abortus in water buffalo

  2007cites this paper
• Flirtations with phage therapy

  2006cites this paper
• A minireview on the in vitro and in vivo experiments with anti-Escherichia coli O 157 Sabouri , Salehe 2017-02-21

  year unknowncites this paper